• Nitroaromatic Nannocystin Targets AKT1 in Colorectal Cancer

  2026-09-03

  The reference study identifies a nitroaromatic nannocystin, compound 4, as a nanomolar inhibitor of colorectal cancer models and links its activity to AKT1 using transcriptomics, molecular docking, and cellular thermal shift analysis. Its activity across cell lines, patient-derived organoids, and a patient-derived xenograft model provides a useful preclinical framework for evaluating macrocyclic targeted agents.

• Ceftolozane Sulfate: From Target to Translation

  2026-09-03

  A thought-leadership guide for translating Ceftolozane sulfate from PBP-directed cell-wall inhibition into susceptibility, resistance, and PK/PD study design for resistant Pseudomonas aeruginosa.

• Verteporfin A8327: Reliable Cell Assays

  2026-09-02

  A scenario-based guide to using Verteporfin (SKU A8327) in viability, apoptosis, proliferation, and autophagy experiments. It explains light-dependent cytotoxicity, light-independent pathway effects, formulation controls, protocol parameters, and practical product-selection criteria for reproducible laboratory workflows.

• CENPI Drives Breast Cancer via Wnt/β-Catenin

  2026-09-02

  Wu and colleagues identify centromere protein I (CENPI) as an overexpressed breast cancer driver associated with disease progression and poor prognosis. By combining patient-data analysis, cellular assays, xenograft models, RNA sequencing, and Wnt/β-catenin reporter validation, the study connects a chromosome-segregation protein to a major oncogenic signaling pathway and suggests a biomarker and therapeutic research direction.

• 10074-G5: A Mechanism-First c-Myc Inhibitor Guide

  2026-09-01

  Explore how 10074-G5, a c-Myc inhibitor, can be used to interrogate MYC-driven phenotypes without confusing pathway correlation with direct target engagement. This mechanism-first guide connects the MYC/TERT/NFκB axis to assay selection, controls, and translational interpretation.

• ZIF-8 Nanotheranostics for Ultrasound-Guided TNBC Therapy

  2026-09-01

  Li et al. developed a folic acid–PEG-functionalized ZIF-8 nanoplatform that delivers ciprofloxacin while supporting ultrasound imaging, sonodynamic therapy, chemotherapy, and immune activation. In triple-negative breast cancer models, ultrasound-triggered ROS generation and immunogenic cell death were associated with stronger tumor control and increased CD8+ T-cell infiltration.

• One-step TUNEL Cy3 Apoptosis Detection Kit

  2026-08-31

  Learn how the One-step TUNEL Cy3 Apoptosis Detection Kit (SKU K1134) supports reproducible DNA-fragmentation measurements across cultured cells and tissue sections. This scenario-based guide covers assay principles, sample compatibility, controls, interpretation, and practical vendor selection for apoptosis research.

• Verteporfin (CL 318952) Assay Workflows

  2026-08-31

  Verteporfin (CL 318952) supports two experimentally distinct use cases: light-triggered photodynamic cell injury and light-independent modulation of autophagy. This guide connects those workflows with apoptosis, ocular neovascularization, and machine-learning-guided senolytic discovery while emphasizing controls, reproducibility, and troubleshooting.

• Clozapine as a Circuit-Level Research Comparator

  2026-08-30

  Clozapine is an atypical antipsychotic medication with multi-receptor activity and ERK1/2 pathway effects. This article presents a translational assay framework for using Clozapine as an orthogonal comparator in schizophrenia research involving prefrontal GABRE regulation and magnetic stimulation.

• Molidustat: Reading HIF Biology in Renal Anemia

  2026-08-29

  Molidustat (BAY85-3934) is examined through the HIF–VHL degradation axis rather than as a simple HIF stabilizer. This article connects renal anemia research with mechanistic assay decisions inspired by evidence from cardiomyocyte hypoxia biology.

• Ceftazidime Workflows for Resistance Profiling

  2026-08-28

  Ceftazidime provides a practical phenotype-first tool for Gram-negative bacterial infection research, especially when Pseudomonas aeruginosa and β-lactamase-mediated resistance are central questions. This workflow pairs ceftazidime susceptibility testing with plasmid analysis, PCR, and transfer assays to distinguish target-level activity from mobile resistance.

• MRTFA-KCNMB1 Control of Cancer Cell Stiffness

  2026-08-28

  The reference study identifies potassium efflux through BK channels and the auxiliary subunit KCNMB1 as regulators of cancer-cell stiffness downstream of MRTFA. By combining mechanical, electrophysiological, transcriptomic, immune-cell, and mouse-model approaches, it connects ionic control of the cytoskeleton with immune escape and metastatic colonization.

• Pyridostatin TFA: G-Quadruplex Workflows

  2026-08-27

  Pyridostatin TFA enables controlled stabilization of G-quadruplex structures for telomere, cancer, and nucleic-acid–protein interaction studies. This guide translates the latest TDP-43 findings into practical assay designs while clearly separating validated product parameters from exploratory neurodegeneration applications.

• YAP-TEAD Control of Surface Ectoderm Super-Enhancers

  2026-08-27

  The reference study maps how super-enhancers and three-dimensional chromatin interactions guide early surface ectoderm commitment from pluripotent stem cells. Its perturbation data identify YAP-TEAD, particularly TEAD activity, as a regulatory driver that promotes early enhancer establishment and lineage-associated gene activation.

• MroGCL and Early Spermatogenesis in Giant Prawn

  2026-08-26

  Molcho and colleagues identified and functionally examined MroGCL, a germ cell-less homolog in the giant prawn Macrobrachium rosenbergii. Developmental expression patterns and RNAi results support a role in early spermatogenic mitosis, although the partial phenotype indicates that MroGCL is not the sole determinant of sperm production.

8027 records 1/536 page Next 12345 下5页 Last page